FDA product code OYM
Prostrate Cancer Genes Nucleic Acid Amplification Test System
Unknown·Class 3·21 CFR
US regulatory classifications
- US Product Code (FDA)
- OYMView Product Code Classification →
- US Risk Class (FDA)
- Class 3
- US Regulation (CFR)
- 21 CFRView CFR Regulation →
- Medical specialty
- Unknown
Device characteristics
- GMP exempt
- No
- Implantable
- No
- Life-sustaining
- No
- Third party review
- Not Eligible
Definition
An in vitro nucleic acid amplification test that measures the concentration of prostate cancer genes.
Search keywords
Click to search for similar devices in our global database
About this record
Prostrate Cancer Genes Nucleic Acid Amplification Test System is a medical device type in the Unknown specialty. This page includes real-world medical device registration data worldwide for this device type, with registrations from US FDA, Brazil ANVISA, and other global markets.
View regulatory classifications, recent 510(k) clearances, active device registrations, and similar products registered globally under this device category. Pure Global AI's free directory provides comprehensive worldwide registration intelligence across 7,000+ medical device types and 21 specialties.